Bicara Therapeutics Inc. (BCAX) at a glance

Bicara Therapeutics Inc. (BCAX) is a small-cap Healthcare company. It trades at $23.43, with a P/E of 3.4 and a 0% profit margin. It does not pay a dividend. Vestovix scores it 63/100 overall. Its strongest dimension is Value (95/100) and its weakest is Income (40/100).

Price
$23.43
Market cap
$1.43B
P/E ratio
3.4
Dividend yield
None
Beta
n/a
52-week range
$10.30 to $30.99
Vestovix Score63/ 100How this works
Value
95
Growth
50
Income
40
Safety
62
Momentum
60

Other Healthcare stocks

See all